Company news
Bioasis Technologies Inc. news in 2021
Bioasis Technologies Inc.'s news releases, calls and decks from 2021, newest first.
Bioasis Announces Annual General Meeting Results
December 16, 2021
Bioasis to Attend and Present at Upcoming Industry Conferences
December 9, 2021
Bioasis Announces Annual General Meeting Details
November 29, 2021
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2021
October 28, 2021
Bioasis to Attend Upcoming Industry Conferences
September 30, 2021
Bioasis Technologies Inc. Announces the Appointment of Shadow Lake Group as Business Development Advisor
August 18, 2021
Bioasis Announces Allowance of Japanese Patent Application in Japan Relating to xB³™ Fusion Protein Comprising Iduronate-2-sulfatase
August 9, 2021
Bioasis Technologies Inc. Announces Stock Option Grants, Jeffrey Sprouse Appointed Preclinical Program Manager
July 20, 2021
Bioasis Announces Positive Results From an Efficacy Study of xB3™-IL-1RA in a Model of Multiple Sclerosis
July 7, 2021
Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer
July 1, 2021
Bioasis Technologies Inc. and Oxyrane UK Ltd. enter into a Research Collaboration
June 30, 2021
Bioasis Technologies Announces Closing of Initial C$3,000,000 Funding by Lind Partners
June 29, 2021
Bioasis Technologies enters into Convertible Security Funding Agreement for Institutional Investment of up to C$10 million
June 22, 2021
Bioasis Announces Publication Validating its xB³ ™ Platform Technology for CNS Therapeutics
June 3, 2021
Bioasis Technologies Inc. and Aposense Enter into a Research Collaboration
March 31, 2021
Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
March 29, 2021
Bioasis Technologies Inc. Confirms TSXV Approval of Warrant Extension and Repricing
March 24, 2021
Bioasis Technologies Inc. Announces Warrant Extension and Repricing
March 22, 2021
Bioasis to Attend and Present at Upcoming Investor and Industry Conferences
March 8, 2021
Bioasis Announces Shares for Debt Transaction
February 10, 2021
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2020
January 27, 2021
Bioasis Announces Stock Option Grant
January 22, 2021
Bioasis to Present at Upcoming Industry Conferences
January 4, 2021